What is Stryker's R&D?

Stryker (SYK) reported R&D of $413M in Q1 2026.

How has Stryker's R&D changed year-over-year?

Stryker's R&D increased by 2.0% year-over-year, from $405M to $413M.

What is the long-term trend for Stryker's R&D?

Over 4 years (2021 to 2025), Stryker's R&D has grown at a 7.1% compound annual growth rate (CAGR), from $1.24B to $1.62B.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Stryker SYK R&D

R&D at other companies

Baxter InternationalBAX

$139M-0.7%

AxogenAXGN

$7.52M+23.4%

CONMEDCNMD

$16.33M+26.2%

Merit Medical SystemsMMSI

$22.61M+0.6%

Orthofix Medical Inc.OFIX

$15.32M-22.5%

VericelVCEL

$8.1M+11.6%

Segments

By segment

See full

MedSurg and Neurotechnology:$231M+11.1%

Orthopaedics$158M—

Other financials

Income statement

See full

Revenue$6.0B+2.6%

Gross profit$3.8B+1.8%

Operating income$936.0M+11.8%

Net income$745.0M+13.9%

EPS (diluted)$1.93+14.2%

Balance sheet

See full

Cash & equivalents$2.9B+24.1%

Total debt$14.4B-15.1%

Total assets$46.3B+0.6%

Cash flow

See full

Operating cash flow$581.0M+132%

CapEx$166.0M+35.0%

Free cash flow$415.0M+227%

Valuation

See full

Market cap$127.55B-13.6%

Enterprise value$139.05B-14.2%

P/E38.2×-12.4×

P/S5.1×-1.2×

Profitability

See full

Gross margin63.8%-0.1pp

Operating margin19.7%+4.4pp

Net margin13.2%+0.9pp

FCF margin18.1%+2.7pp

Returns & leverage

See full

Return on equity32.8%—

Debt / equity0.8×—

Current ratio2.1×+0.5×

Where this comes from

Reported directly by Stryker in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Stryker’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stryker's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Stryker's R&D?: Stryker (SYK) reported R&D of $413M in Q1 2026.
How has Stryker's R&D changed year-over-year?: Stryker's R&D increased by 2.0% year-over-year, from $405M to $413M.
What is the long-term trend for Stryker's R&D?: Over 4 years (2021 to 2025), Stryker's R&D has grown at a 7.1% compound annual growth rate (CAGR), from $1.24B to $1.62B.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.